Opportunity Research

Four Reasons to Buy This Stock

While the stock market’s performance of the past two days is enough to give most investors pause, an opportunity exists to invest in an under-the-radar firm in a fast-growing industry that trades at a low valuation relative to its peers and our price target. We initiated coverage of ML Capital Group (OTCQB – MLCG), an emerging company in the e-cigarette and vapor pen space, in June and the stock more than doubled in a matter of weeks as it had been oversold. The Company, and its industry are on a tremendous sales growth trajectory and we outline four reasons why to buy the stock in our latest research update.

Stock Poised to Double on New Business

Tweet This stock is clearly oversold at current levels and with an expected resurgence in new business, as evidenced by yesterday’s news; we expect the stock to double from here in the near term. In our view, the business model is sound and management is in the early innings of the execution phase of that model. As a result, the current share price illustrates little risk and big upside.
Read more...

The Next Great Cancer Diagnostics Stock

Tweet Today we are initiating coverage of what we believe is the next great cancer diagnostics stock. Its tools address four of the most deadly cancers and are primed to come to market with a unique and highly effective product that does not require FDA approval. Therefore its flagship product will be available for sale in about a year or so.
Read more...

The Top Vapor Pen Opportunity

Tweet Today we are initiating coverage of what we believe is the most attractive price/valuation opportunity in the fast-growing e-cig, or vapor pen market.
Read more...

Huge Pre-Release Subscriber Figures to Drive Stock Value

Tweet It should be noted CHICF recently reached a peak price of $1.64, which is 34% higher than our initiation price in January of this year. Clearly, despite the difficult environment for technology stocks, CHICF is not correlated to these issues and the strength of the relative stock performance should prove to be a precursor for future, outsized gains.
Read more...

Our Top Stock Pick Is More Than a Double from Here

Tweet Since we entered the sponsored research arena roughly five years ago I do not think we have ever labeled a stock as our top stock pick. Times are changing and so will we because we are announcing to the world that our top stock pick, without question, is ForeverGreen Worldwide (OTCQB - $1.54).
Read more...

The Next Big Energy Services Player

Tweet On the heels of a new pick last week, which rose by over 40%, we are introducing a new report on a soon-to-be major player in energy/electricity services, supply and efficiency. The stock is likely worth 5x its current market cap given its 40,000 residential and 1500 commercial customers and world-class management team.
Read more...

A Rare, Revenue Generating Cannabis Play

Those of you that follow the cannabis sector know that valuations have been cut stocks halted and the bottom feeders that are not ready for prime time have been thrown by the wayside. We all know the huge opportunity here but the difficulty is assessing who will emerge as winners. The easy answer is to invest in the few revenue-generating companies such as Interactive Health Network (OTCPK – IGRW), which is today’s new sponsored research recommendation.